[
  {
    "date": "2023-12-30",
    "symbol": "CPHI",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 1423838,
    "bankersacceptances": 65915,
    "accountsreceivablenetcurrent": 504448,
    "otherreceivablesnetcurrent": 157944,
    "advancetosupplies": 2013,
    "inventorynet": 3732517,
    "prepaidexpensecurrent": 110258,
    "assetscurrent": 5996933,
    "propertyplantandequipmentnet": 7100425,
    "operatingleaserightofuseasset": 116610,
    "intangibleassetsnetexcludinggoodwill": 3255232,
    "assets": 16469200,
    "accountspayabletradecurrent": 966420,
    "accruedliabilitiescurrent": 298829,
    "accountspayableothercurrent": 2282692,
    "contractwithcustomerliabilitycurrent": 90507,
    "otherliabilitiescurrent": 1133809,
    "operatingleaseliabilitycurrent": 77727,
    "linesofcreditcurrent": 1030680,
    "convertiblenotespayablecurrent": 940000,
    "liabilitiescurrent": 6820664,
    "operatingleaseliabilitynoncurrent": 39910,
    "longtermlineofcredit": 1411891,
    "deferredincometaxliabilitiesnet": 742114,
    "liabilities": 9014579,
    "commonstockvalue": 10625,
    "additionalpaidincapital": 35282256,
    "retainedearningsaccumulateddeficit": -39290314,
    "accumulatedothercomprehensiveincomelossnetoftax": 11452054,
    "stockholdersequity": 7454621,
    "liabilitiesandstockholdersequity": 16469200,
    "allowancefordoubtfulaccountsreceivablecurrent": 13786074,
    "otherreceivableslessallowancefordoubtfulaccounts": 27017,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 10625788,
    "commonstocksharesoutstanding": 10625788,
    "revenues": 7011299,
    "costofrevenue": 7292384,
    "grossprofit": -281085,
    "sellingexpense": 780328,
    "generalandadministrativeexpense": 1466084,
    "researchanddevelopmentexpense": 240080,
    "provisionfordoubtfulaccounts": -15757,
    "operatingexpenses": 2470735,
    "operatingincomeloss": -2751820,
    "investmentincomeinterest": 6602,
    "interestexpense": 333600,
    "nonoperatingincomeexpense": -326998,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3078818,
    "netincomeloss": -3078818,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -121011,
    "comprehensiveincomenetoftax": -3199829,
    "earningspersharebasic": -0.91,
    "weightedaveragenumberofsharesoutstandingbasic": 3383573,
    "earningspersharediluted": -0.91,
    "stockissuedduringperiodvalueacquisitions": 3000,
    "stockissuedduringperiodsharespurchaseofassets": 3000000,
    "stockissuedduringperiodvalueconversionofunits": 2751,
    "stockissuedduringperiodsharesconversionofunits": 2751412,
    "stockissuedduringperiodvaluestocksplits": 14,
    "stockissuedduringperiodsharesreversestocksplits": 14085,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 3362,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 3362111,
    "foreigncurrencytransactiongainlossbeforetax": -121011,
    "depreciationdepletionandamortization": 2753653,
    "gainlossonsaleofpropertyplantequipment": -45385,
    "increasedecreaseinaccountsandotherreceivables": 938021,
    "increasedecreaseinprepaidsupplies": -437431,
    "increasedecreaseininventories": 25032,
    "increasedecreaseinaccountspayabletrade": 312045,
    "increasedecreaseinaccruedliabilities": 257778,
    "increasedecreaseincontractwithcustomerliability": -423261,
    "increasedecreaseinprepaidexpensesother": 25089,
    "netcashprovidedbyusedinoperatingactivities": -699686,
    "paymentsforproceedsfromproductiveassets": 11517,
    "netcashprovidedbyusedininvestingactivities": -11517,
    "repaymentsoflinesofcredit": 1490049,
    "proceedsfromlinesofcredit": 1532622,
    "proceedsfromrelatedpartydebt": 30572,
    "netcashprovidedbyusedinfinancingactivities": 73145,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 31925,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -606133,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 1423838,
    "interestpaidnet": 92439,
    "accountsreceivablecollectedwithbankersacceptances": 865733,
    "inventorypurchasedwithbankersacceptancenote": 813105,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 156273,
    "stockissued1": 1650000,
    "conversionofrelatedpartynoteandinteresttocommonstock": 1854542,
    "liquidityandgoingconcernpolicytextblock": "Liquidity and Going Concern",
    "reversestocksplitspolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"><b><i>Reverse Stock Split </i></b>–Effective March 6, 2024, the Company implemented a 1-for-5 reverse stock split as more fully discussed in Note 14. All share and pershare disclosures have been retroactively restated to reflect the impact of the reverse stock split.</p>",
    "interestrateriskpolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"><b><i>Interest Rate Risk</i></b> –The Company is exposed to the risk arising from changing interest rates, which may affect the ability of repayment of existing debts andviability of securing future debt instruments within the PRC.</p>",
    "usefulliveofassetstabletextblock": "Depreciation is computed on a straight-line basis over the estimateduseful lives of the assets as follows:",
    "inventoryrawmaterials": 1849213,
    "inventoryworkinprocess": 413597,
    "inventoryfinishedgoods": 1469707,
    "propertyplantandequipmentgross": 397684,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 30394655,
    "propertyplantandequipmentothernet": 7100425,
    "propertyplantandequipmentusefullife": "P40Y",
    "finitelivedintangibleassetsgross": 4766353,
    "finitelivedintangibleassetsaccumulatedamortization": 4890646,
    "finitelivedintangibleassetsnet": 3255232,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 327050,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 321235,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 292156,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 292156,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 292156,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 1730479,
    "accruedsalariescurrent": 1243506,
    "otheremployeerelatedliabilitiescurrent": 12000,
    "taxespayablecurrent": 1027186,
    "accountspayableandaccruedliabilitiescurrent": 2282692,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 2442571,
    "longtermdebt": 2442571,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 80647,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 40324,
    "lesseeoperatingleaseliabilitypaymentsdue": 120971,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 3334,
    "operatingleaseliability": 117637,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -769704,
    "incometaxreconciliationchangeinenactedtaxrate": 3382,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 766322,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.25,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 3446519,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsprovisionforloanlosses": 6754,
    "deferredtaxassetsinventory": 32355,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3201,
    "deferredtaxassetstaxdeferredexpenseother": 1069198,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsimpairmentlosses": 9619060,
    "deferredtaxassetsother": 257,
    "deferredtaxassetstaxcreditcarryforwards": 5275411,
    "deferredtaxassetsoperatinglosscarryforwards": 2078262,
    "deferredtaxassetsgross": 21531017,
    "deferredtaxassetsvaluationallowance": 21531017,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 742114,
    "fairvaluenetassetliability": 65915,
    "minorityinterestownershippercentagebyparent": 1,
    "othercashequivalentsatcarryingvalue": 1400000,
    "retainedearningsappropriated": -39300000,
    "workingcapital": 1133809,
    "interestexpensedebt": 15757,
    "optionindexedtoissuersequityindexedshares": 13300,
    "saleofstocknumberofsharesissuedintransaction": 6267,
    "depreciation": 2529858,
    "finitelivedintangibleassetsamortizationmethod": "Approved medical formulas are amortized from thedate NMPA approval is obtained over their individually identifiable estimated useful life, which range from ten to thirteen years.",
    "amortizationofintangibleassets": 223796,
    "finitelivedintangibleassetusefullife": "P14Y9M18D",
    "percentageofnetprofit": 0.15,
    "debtinstrumentinterestratestatedpercentage": 0.01,
    "interestincomeexpensenet": 6773,
    "accountspayableothercurrentandnoncurrent": 12000,
    "prepaymentfeesonadvancesnet": 2928,
    "loansheldforsaleterm": "P1Y",
    "investmentinterestratefloor": 0.0425,
    "interestexpenseother": 31750,
    "debtinstrumentredemptionpricepercentageofprincipalamountredeemed": 0.82,
    "debtinstrumentconvertiblenumberofequityinstruments": 35000,
    "debtinstrumentconvertibleconversionprice1": 150,
    "interestaccruesonnotedescription": "Interest accrues on theoutstanding balance of the Note at 5% per annum compounded daily. Upon the occurrence of an Event of Default as defined in the Note, interestaccrues at the lesser of 22% per annum or the maximum rate permitted by applicable law. In addition, upon any Event of Default, the Investormay accelerate the outstanding balance payable under the Note, which will increase automatically upon such acceleration by 15% or 5%,depending on the nature of the Event of Default.",
    "redeemofoutstandingnote": 500000,
    "debtinstrumentredemptionpricepercentage": 0.82,
    "noteredeemableintoshares": 2159964,
    "weightedaverageprice": 0.436,
    "operatingleasecost": 77265,
    "operatingleasepayments": 80647,
    "operatingleasepaymentsuse": 117637,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.0475,
    "effectiveincometaxratereconciliationtaxcredits": 0.25,
    "operatinglosscarryforwards": 3400000,
    "operatinglosscarryforwardsvaluationallowance": 5100000,
    "operatinglosscarryforwardslimitationsonuse": "through 2039, and $4.8 million are available for carryforward indefinitely subject to a limitation of 80% of taxable income for eachtax year",
    "deferredtaxassetvaluationallowance": 21531017,
    "aftertaxnetincomepercentage": 0.1,
    "reserveaccountbalancespercentage": 0.5,
    "statutoryaccountingpracticesstatutorycapitalandsurplusrequired": 8145000,
    "stockholdersequityreversestocksplit": "1-for -5",
    "stockissuedduringperiodsharesemployeebenefitplan": 580000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 84700,
    "totaloptionoutstanding": 13300,
    "additionalsharesavailableforissuance": 482000,
    "concentrationriskpercentage1": 0.1,
    "aggregateamount": 1.365,
    "sharesissuedpricepershare": 0.455,
    "redemptionpercentage": 0.1,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "China Pharma Holdings, Inc.",
    "entitycentralindexkey": 1106644,
    "entityfilenumber": "001-34471",
    "entitytaxidentificationnumber": "73-1564807",
    "entityincorporationstatecountrycode": "NV",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityaddressaddressline1": "Second Floor, No. 17, Jinpan Road",
    "entityaddressaddressline2": "Haikou",
    "entityaddresscityortown": "Hainan Province",
    "entityaddresscountry": "CN",
    "entityaddresspostalzipcode": 570216,
    "cityareacode": "(011)",
    "localphonenumber": "86 898-6681-1730",
    "security12btitle": "Common Stock",
    "tradingsymbol": "CPHI",
    "securityexchangename": "NYSE",
    "auditorname": "BF Borgers CPA PC",
    "auditorfirmid": 5041,
    "auditorlocation": "Lakewood, CO"
  },
  {
    "date": "2022-12-30",
    "symbol": "CPHI",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 2029971,
    "bankersacceptances": 13784,
    "tradeaccountsreceivablelessallowancefordoubtfulaccounts": 421531,
    "accountsandotherreceivablesnetcurrent": 29139,
    "advancetosupplies": 444637,
    "inventorynet": 2947787,
    "prepaidexpensecurrent": 77697,
    "assetscurrent": 5964546,
    "propertyplantandequipmentnet": 9973065,
    "operatingleaserightofuseasset": 39046,
    "intangibleassetsnetexcludinggoodwill": 1807486,
    "assets": 17784143,
    "accountspayabletradecurrent": 667082,
    "accruedliabilitiescurrent": 404807,
    "accountspayableothercurrent": 2390063,
    "contractwithcustomerliabilitycurrent": 520295,
    "otherliabilitiescurrent": 2475840,
    "operatingleaseliabilitycurrent": 40445,
    "linesofcreditcurrent": 2440915,
    "longtermconstructionloancurrent": 3800000,
    "liabilitiescurrent": 12739447,
    "deferredincometaxliabilitiesnet": 754698,
    "liabilities": 13494145,
    "commonstockvalue": 74909,
    "additionalpaidincapital": 28853520,
    "retainedearningsaccumulateddeficit": -36211496,
    "accumulatedothercomprehensiveincomelossnetoftax": 11573065,
    "stockholdersequity": 11573065,
    "liabilitiesandstockholdersequity": 17784143,
    "tradeaccountsreceivablelessallowance": 16739527,
    "otherreceivableslessallowancefordoubtfulaccounts": 27149,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 7490896,
    "commonstocksharesoutstanding": 7490896,
    "revenues": 8104092,
    "costofrevenue": 8598008,
    "grossprofit": -493916,
    "sellingexpense": 1069785,
    "generalandadministrativeexpense": 1893269,
    "researchanddevelopmentexpense": 185858,
    "provisionfordoubtfulaccounts": -93851,
    "operatingexpenses": 3055061,
    "operatingincomeloss": -3548977,
    "investmentincomeinterest": 10755,
    "interestexpense": 434619,
    "nonoperatingincomeexpense": -423864,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3972841,
    "netincomeloss": -3972841,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -990764,
    "comprehensiveincomenetoftax": -4963605,
    "earningspersharebasic": -0.76,
    "weightedaveragenumberofsharesoutstandingbasic": 5256855,
    "earningspersharediluted": -0.76,
    "sharesoutstanding": 7490896,
    "stockissuedduringperiodvalueacquisitions": 1707452,
    "stockissuedduringperiodsharesacquisitions": 1552229,
    "stockissuedduringperiodvalueother": 42000,
    "stockissuedduringperiodsharesother": 30000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 1450000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 1174711,
    "stockissuedduringperiodvaluesharebasedcompensation": 36270,
    "profitloss": -3972841,
    "foreigncurrencytransactiongainlossbeforetax": -990764,
    "depreciationdepletionandamortization": 2700533,
    "stockoptionplanexpense": 78270,
    "increasedecreaseinaccountsandotherreceivables": 170194,
    "advancestosuppliers": 459959,
    "increasedecreaseininventories": -689104,
    "increasedecreaseinaccountspayabletrade": -187734,
    "increasedecreaseinaccruedliabilities": 692190,
    "increasedecreaseincontractwithcustomerliability": 339659,
    "increasedecreaseinprepaidexpense": 24722,
    "netcashprovidedbyusedinoperatingactivities": -409545,
    "paymentstoacquirepropertyplantandequipment": 401964,
    "netcashprovidedbyusedininvestingactivities": -401964,
    "proceedsfromlongtermlinesofcredit": -2140921,
    "proceedsfromlinesofcredit": 564965,
    "proceedsfromrelatedpartydebt": 28962,
    "repaymentsofrelatedpartydebt": 223013,
    "netcashprovidedbyusedinfinancingactivities": -1770007,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -247572,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -2829088,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2029971,
    "interestpaidnet": 141797,
    "accountsreceivablecollectedwithbankersacceptances": 503383,
    "inventorypurchasedwithbankersacceptancenote": 575713,
    "conversionofofficerwagestocommonstock": 1707452,
    "organizationandnatureofoperationspolicytextblock": "Organizationand Nature of Operations – China Pharma Holdings, Inc., a Nevada corporation (the “Company”), owns 100%of Onny Investment Limited (“Onny”), a British Virgin Islands corporation, which owns 100% of Hainan Helpson Medical &Biotechnology Co., Ltd (“Helpson”), a company organized under the laws of the People’s Republic of China (the “PRC”).China Pharma Holdings, Inc. and its subsidiaries are referred to herein as the Company. ",
    "liquidityandgoingconcernpolicytextblock": "Liquidityand Going Concern ",
    "interestrateriskpolicytextblock": "InterestRate Risk – The Company is exposed to the risk arising from changing interest rates, which may affect the abilityof repayment of existing debts and viability of securing future debt instruments within the PRC. ",
    "usefulliveofassetstabletextblock": "      Asset     Life - years      Permit of land use     40 - 70      Building     20 - 49      Plant, machinery and equipment     5 - 10      Motor vehicle     5 - 10      Office equipment     3-5   ",
    "inventoryrawmaterials": 1839641,
    "inventoryworkinprocess": 557146,
    "inventoryfinishedgoods": 551000,
    "landandlandimprovements": 404427,
    "buildingsandimprovementsgross": 9391433,
    "machineryandequipmentgross": 27780585,
    "motorvehiclegross": 438138,
    "officeequipmentgross": 308847,
    "propertyplantandequipmentgross": 38323430,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 28350365,
    "propertyplantandequipmentothernet": 9973065,
    "propertyplantandequipmentusefullife": 5,
    "finitelivedintangibleassetsgross": 6554628,
    "finitelivedintangibleassetsaccumulatedamortization": 4747142,
    "finitelivedintangibleassetsnet": 1807486,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 211939,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 211939,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 206055,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 176632,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 176632,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 824289,
    "impairmentofintangibleassetsexcludinggoodwill": 1807486,
    "notespayablerelatedpartiesclassifiedcurrent": 951506,
    "notespayablerelatedpartiesnoncurrent": 372578,
    "accountspayableandaccruedliabilitiescurrent": 1065979,
    "otherliabilities": 2390063,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 2440915,
    "longtermdebt": 2440915,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 41007,
    "lessoroperatingleasepaymentstobereceived": 41007,
    "receivablewithimputedinterestnetamount": 562,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 40445,
    "lessoperatingleaseliabilitiescurrentportion": 40445,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -973717,
    "incometaxreconciliationchangeinenactedtaxrate": 8416,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 965301,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.25,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 4184882,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsprovisionforloanlosses": 6787,
    "deferredtaxassetsinventory": 34921,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3201,
    "deferredtaxassetstaxdeferredexpenseother": 1087328,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsimpairmentlosses": 9782172,
    "deferredtaxassetsother": 349,
    "deferredtaxassetstaxcreditcarryforwards": 5036114,
    "operatinglosscarryforwards": 1849800,
    "deferredtaxassetsgross": 21985554,
    "deferredtaxassetsvaluationallowance": 21985554,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 754698,
    "customersliabilityforacceptancesnet": 13784,
    "fairvaluenetassetliability": 13784,
    "equitymethodinvestmentownershippercentage": 1,
    "restrictedcashandcashequivalentsatcarryingvalue": 2000000,
    "accumulateddeficit": 36200000,
    "capitalrequiredforcapitaladequacy": 1121273,
    "interestexpensedebt": 93851,
    "purchaseofcommonstockshares": 96500,
    "stockissuedduringperiodsharesconversionofunits": 126667,
    "depreciation": 2663975,
    "intangibleassetsusefullifedescription": "Approvedmedical formulas are amortized from the date NMPA approval is obtained over their individually identifiable estimated useful life, whichrange from ten to thirteen years.",
    "amortizationofintangibleassets": 36558,
    "finitelivedintangibleassetusefullife": 9.7,
    "duetootherrelatedpartiesclassifiedcurrent": 1354567,
    "debtinstrumentinterestrateeffectivepercentage": 0.01,
    "interestexpenserelatedparty": 28962,
    "accountspayableothercurrentandnoncurrent": 372578,
    "duefromrelatedpartiescurrent": 223013,
    "duefromrelatedparties": 1121273,
    "othernotespayable": 951506,
    "constructionloan": 440000,
    "interestexpenseother": 53283,
    "revenueremainingperformanceobligation": 5900000,
    "interestrate": 0.045,
    "interestamount": 54923,
    "convertiblenote": 175000,
    "convertiblenoteconversionprice": 30,
    "interestaccruesonnotedescription": "Interestaccrues on the outstanding balance of the Note at 5% per annum compounded daily. Upon the occurrence of an Event of Default as definedin the Note, interest accrues at the lesser of 22% per annum or the maximum rate permitted by applicable law. In addition, upon any Eventof Default, the Investor may accelerate the outstanding balance payable under the Note, which will increase automatically upon such accelerationby 15% or 5%, depending on the nature of the Event of Default. ",
    "redeemofoutstandingnote": 500000,
    "percentageofcommonstockpriceonweightedaverageprice": 0.85,
    "noteredeemableintoshares": 3836070,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 85,
    "weightedaverageprice": 0.991,
    "interestanddebtexpense": 250314,
    "operatingleasecost": 78092,
    "cashflowforoperatinglease": 82015,
    "operatingleaserightsofuseassets": 39046,
    "operatingleaseliability": 40445,
    "weightedaveragesremainingleaseterm": 0.5,
    "weightedaveragediscountrate": 0.0475,
    "effectiveincometaxratecontinuingoperations": 0.25,
    "deferredtaxassetsoperatinglosscarryforwards": 20100000,
    "netoperatinglosscarryforwardsexpirationdescription": "Approximately $6.0 million of these carryforwards expired in December 2022.The Company also has net operating losses for United States federal income tax purposes of approximately $8.7 million of which $5.1 millionis available to offset future taxable income, if any, through 2039, and $3.7 million are available for carryforward indefinitely subjectto a limitation of 80% of taxable income for each tax year.",
    "valuationallowancefordeferredtaxassets": 21985554,
    "aftertaxnetincomepercentage": 0.1,
    "reserveaccountbalancespercentage": 0.5,
    "statutoryaccountingpracticesstatutorynetincomeamount": 8145000,
    "stockissuedduringperiodsharesemployeebenefitplan": 1400000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 490000,
    "totaloptionoutstanding": 66500,
    "additionalsharesavailableforissuance": 910000,
    "concentrationriskpercentage": 0.125,
    "numberofcustomers": 3,
    "numberofsuppliers": 3,
    "entityregistrantname": "China Pharma Holdings, Inc.",
    "tradingsymbol": "CPHI",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1106644,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34471",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "73-1564807",
    "entityaddressaddressline1": "Second Floor, No. 17, Jinpan Road",
    "entityaddressaddressline2": "Haikou",
    "entityaddresscityortown": "Hainan Province",
    "entityaddresscountry": "China",
    "entityaddresspostalzipcode": 570216,
    "cityareacode": 86,
    "localphonenumber": "898-6681-1730",
    "security12btitle": "Common Stock",
    "securityexchangename": "NYSE",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "B F Borgers CPA PC",
    "auditorlocation": "Lakewood,Colorado",
    "auditorfirmid": 5041
  },
  {
    "date": "2021-12-30",
    "symbol": "CPHI",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 4859059,
    "bankersacceptances": 91362,
    "tradeaccountsreceivablelessallowancefordoubtfulaccounts": 714475,
    "accountsandotherreceivablesnetcurrent": 29564,
    "advancetosupplies": 471,
    "inventorynet": 3339686,
    "prepaidexpensecurrent": 58792,
    "assetscurrent": 9093409,
    "propertyplantandequipmentnet": 13280559,
    "operatingleaserightofuseasset": 127958,
    "intangibleassetsnetexcludinggoodwill": 147841,
    "assets": 22649767,
    "accountspayabletradecurrent": 926749,
    "accruedliabilitiescurrent": 298452,
    "accountspayableothercurrent": 1884161,
    "contractwithcustomerliabilitycurrent": 210028,
    "otherliabilitiescurrent": 2779690,
    "operatingleaseliabilitycurrent": 85282,
    "linesofcreditcurrent": 4328936,
    "liabilitiescurrent": 10513298,
    "convertiblelongtermnotespayable": 5250000,
    "operatingleaseliabilitynoncurrent": 44181,
    "deferredincometaxliabilitiesnet": 824407,
    "liabilities": 16631886,
    "commonstockvalue": 47340,
    "additionalpaidincapital": 25645367,
    "retainedearningsaccumulateddeficit": -32238655,
    "accumulatedothercomprehensiveincomelossnetoftax": 12563829,
    "stockholdersequity": 12563829,
    "liabilitiesandstockholdersequity": 22649767,
    "tradeaccountsreceivablelessallowance": 18312707,
    "otherreceivableslessallowancefordoubtfulaccounts": 32210,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 95000000,
    "commonstocksharesissued": 47339557,
    "commonstocksharesoutstanding": 47339557,
    "revenues": 9641925,
    "costofrevenue": 9292655,
    "grossprofit": 349270,
    "sellingexpense": 1495007,
    "generalandadministrativeexpense": 1651024,
    "researchanddevelopmentexpense": 318964,
    "provisionfordoubtfulaccounts": -255215,
    "operatingexpenses": 3209780,
    "operatingincomeloss": -2860510,
    "investmentincomeinterest": 3035,
    "interestexpense": 22258,
    "nonoperatingincomeexpense": -538966,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3399476,
    "netincomeloss": -3399476,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 218383,
    "comprehensiveincomenetoftax": -3181093,
    "earningspersharebasicanddiluted": -0.07,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 46129256,
    "sharesoutstanding": 47339557,
    "stockissuedduringperiodvaluesharebasedcompensation": 15243,
    "stockissuedduringperiodvalueissuedforservices": 1179200,
    "stockissuedduringperiodsharesissuedforservices": 1760000,
    "profitloss": -3399476,
    "foreigncurrencytransactiongainlossbeforetax": 218383,
    "depreciationdepletionandamortization": 3087820,
    "stockoptionplanexpense": 15243,
    "accretionamortizationofdiscountsandpremiumsinvestments": -250000,
    "increasedecreaseinaccountsandotherreceivables": 545534,
    "advancestosuppliers": -1798,
    "increasedecreaseininventories": -1011905,
    "increasedecreaseinaccountspayabletrade": -332779,
    "increasedecreaseinaccruedliabilities": 415309,
    "increasedecreaseincontractwithcustomerliability": -520414,
    "increasedecreaseinprepaidexpense": -21505,
    "netcashprovidedbyusedinoperatingactivities": -249838,
    "paymentstoacquirepropertyplantandequipment": 438055,
    "netcashprovidedbyusedininvestingactivities": -438055,
    "repaymentsofconstructionloanspayable": 2325039,
    "repaymentsoflinesofcredit": 2526542,
    "proceedsfromrelatedpartydebt": 1183414,
    "repaymentsofrelatedpartydebt": 562659,
    "proceedsfromissuanceofconvertiblepreferredstock": 5000000,
    "proceedsfromlinesofcredit": 3828564,
    "netcashprovidedbyusedinfinancingactivities": 4597738,
    "effectofexchangerateoncashandcashequivalents": -8439,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 3901406,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 4859059,
    "interestpaidnet": 218232,
    "accountsreceivablecollectedwithbankersacceptances": 601021,
    "inventorypurchasedwithbankersacceptancenote": 565079,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 168606,
    "organizationandnatureofoperationspolicytextblock": "Organization and Nature of Operations – ChinaPharma Holdings, Inc., a Nevada corporation (the “Company”), owns 100% of Onny Investment Limited (“Onny”), aBritish Virgin Islands corporation, which owns 100% of Hainan Helpson Medical & Biotechnology Co., Ltd (“Helpson”), acompany organized under the laws of the People’s Republic of China (the “PRC”). China Pharma Holdings, Inc. and itssubsidiaries are referred to herein as the Company. ",
    "liquidityandgoingconcernpolicytextblock": "Liquidity and Going Concern ",
    "interestrateriskpolicytextblock": "Interest Rate Risk –The Company is exposed to the risk arising from changing interest rates, which may affect the ability of repayment of existing debts andviability of securing future debt instruments within the PRC. ",
    "usefulliveofassetstabletextblock": "      Asset          Life    - years       Permit of land use         40 - 70      Building         20 - 49      Plant, machinery and equipment         5 - 10      Motor vehicle         5 - 10      Office equipment         3 - 5   ",
    "inventoryrawmaterials": 2131584,
    "inventoryworkinprocess": 622380,
    "inventoryfinishedgoods": 585722,
    "landandlandimprovements": 441783,
    "buildingsandimprovementsgross": 10258885,
    "machineryandequipmentgross": 30122235,
    "motorvehiclegross": 337375,
    "officeequipmentgross": 278892,
    "propertyplantandequipmentgross": 41439170,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 28158611,
    "propertyplantandequipmentothernet": 13280559,
    "propertyplantandequipmentusefullife": 5,
    "finitelivedintangibleassetsgross": 5294892,
    "finitelivedintangibleassetsaccumulatedamortization": 5147051,
    "finitelivedintangibleassetsnet": 147841,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 38567,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 38567,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 38567,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 32140,
    "notespayablerelatedpartiesclassifiedcurrent": 715506,
    "notespayablerelatedpartiesnoncurrent": 327033,
    "accountspayableandaccruedliabilitiescurrent": 841622,
    "otherliabilities": 1884161,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 4328936,
    "longtermdebt": 4328936,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 89590,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 44795,
    "lessoroperatingleasepaymentstobereceived": 134385,
    "receivablewithimputedinterestnetamount": 4923,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 129462,
    "lessoperatingleaseliabilitiescurrentportion": 85282,
    "operatingleaseliabilitiesnetofcurrentportion": 44180,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -849869,
    "incometaxreconciliationchangeinenactedtaxrate": 8440,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 841429,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.25,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 4578177,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsprovisionforloanlosses": 8052,
    "deferredtaxassetsinventory": 137549,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3201,
    "deferredtaxassetstaxdeferredexpenseother": 1187760,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsimpairmentlosses": 10685714,
    "deferredtaxassetsother": 376,
    "deferredtaxassetstaxcreditcarryforwards": 5779437,
    "operatinglosscarryforwards": 1602243,
    "deferredtaxassetsgross": 23982509,
    "deferredtaxassetsvaluationallowance": 23982509,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 824407,
    "customersliabilityforacceptancesnet": 91362,
    "fairvaluenetassetliability": 91362,
    "equitymethodinvestmentownershippercentage": 1,
    "restrictedcashandcashequivalentsatcarryingvalue": 4900000,
    "accumulateddeficit": 32200000.000000004,
    "capitalrequiredforcapitaladequacy": 1425123,
    "interestexpensedebt": 255215,
    "purchaseofcommonstockshares": 65000,
    "stockissuedduringperiodsharesconversionofunits": 3500000,
    "depreciation": 3049706,
    "intangibleassetsusefullifedescription": "Approved medical formulas are amortized from thedate NMPA approval is obtained over their individually identifiable estimated useful life, which range from ten to thirteen years.",
    "amortizationofintangibleassets": 38114,
    "duetootherrelatedpartiesclassifiedcurrent": 1183414,
    "debtinstrumentinterestrateeffectivepercentage": 0.01,
    "interestexpenserelatedparty": 30194,
    "accountspayableothercurrentandnoncurrent": 327033,
    "duefromrelatedpartiescurrent": 562659,
    "duefromrelatedparties": 1425123,
    "othernotespayable": 715506,
    "notespayable": 1179200,
    "compensationconverted": 1760000,
    "shareprice": 0.67,
    "debtinstrumentfaceamount": 2325039,
    "interestamount": 15582,
    "originalissuediscount": 250000,
    "debtinstrumentconvertiblenumberofequityinstruments": 1750000,
    "debtinstrumentconvertibleconversionprice1": 3,
    "interestaccruesonnotedescription": "Interest accrues on theoutstanding balance of the Note at 5% per annum compounded daily. Upon the occurrence of an Event of Default as defined in the Note, interestaccrues at the lesser of 22% per annum or the maximum rate permitted by applicable law. In addition, upon any Event of Default, the Investormay accelerate the outstanding balance payable under the Note, which will increase automatically upon such acceleration by 15% or 5%,depending on the nature of the Event of Default. ",
    "redeemofoutstandingnote": 500000,
    "percentageofcommonstockpriceonweightedaverageprice": 0.85,
    "noteredeemableintoshares": 11975447,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.438397,
    "interestanddebtexpense": 279979,
    "operatingleasecost": 92085,
    "cashflowforoperatinglease": 98845,
    "operatingleaserightsofuseassets": 127958,
    "operatingleaseliability": 85282,
    "weightedaveragesremainingleaseterm": 1.5,
    "weightedaveragediscountrate": 0.0475,
    "effectiveincometaxratecontinuingoperations": 0.25,
    "deferredtaxassetsoperatinglosscarryforwards": 23100000,
    "netoperatinglosscarryforwardsexpirationdescription": "Approximately $20.4 million of these carryforwards expired in December 2021. The Company also has net operating losses for UnitedStates federal income tax purposes of approximately $7.6 million of which $5.1 million is available to offset future taxable income, ifany, through 2039, and $2.5 million are available for carryforward indefinitely subject to a limitation of 80% of taxable income for eachtax year.",
    "valuationallowancefordeferredtaxassets": 23982509,
    "aftertaxnetincomepercentage": 0.1,
    "reserveaccountbalancespercentage": 0.5,
    "statutoryaccountingpracticesstatutorynetincomeamount": 8145000,
    "stockissuedduringperiodsharesemployeebenefitplan": 9000000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 3935000,
    "totaloptionoutstanding": 65000,
    "additionalsharesavailableforissuance": 5000000,
    "concentrationriskpercentage": 0.135,
    "numberofcustomers": 3,
    "numberofsuppliers": 3,
    "entityregistrantname": "China Pharma Holdings, Inc.",
    "tradingsymbol": "CPHI",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1106644,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-34471",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "73-1564807",
    "entityaddressaddressline1": "Second Floor, No. 17, Jinpan Road",
    "entityaddressaddressline2": "Haikou",
    "entityaddresscityortown": "Hainan Province",
    "entityaddresscountry": "China",
    "entityaddresspostalzipcode": 570216,
    "cityareacode": 86,
    "localphonenumber": "898-6681-1730",
    "security12btitle": "Common Stock",
    "securityexchangename": "NYSE",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "B F Borgers CPA PC",
    "auditorlocation": "Lakewood, Colorado",
    "auditorfirmid": 5041
  },
  {
    "date": "2020-12-30",
    "symbol": "CPHI",
    "period": "FY",
    "entityregistrantname": "CHINA PHARMA HOLDINGS, INC.",
    "entitycentralindexkey": 1106644,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-34471",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "cashandcashequivalentsatcarryingvalue": 21187,
    "bankersacceptances": 53736,
    "receivablesnetcurrent": 501892,
    "accountsandotherreceivablesnetcurrent": 27652,
    "advancetosupplies": 2238,
    "inventorynet": 3705119,
    "prepaidexpensecurrent": 73668,
    "assetscurrent": 21187,
    "propertyplantandequipmentnet": 15564200,
    "operatingleaserightofuseasset": 49687,
    "intangibleassetsnetexcludinggoodwill": 182146,
    "assets": 19473207,
    "accountspayabletradecurrent": 1234594,
    "accruedliabilitiescurrent": 177359,
    "accountspayableothercurrent": 2748208,
    "contractwithcustomerliabilitycurrent": 719786,
    "otherliabilitiescurrent": 2134428,
    "operatingleaseliabilitycurrent": 52070,
    "longtermconstructionloancurrent": 2298886,
    "linesofcreditcurrent": 2038345,
    "liabilitiescurrent": 11403676,
    "longtermlineofcredit": 904228,
    "deferredincometaxliabilitiesnet": 805556,
    "liabilities": 13113460,
    "commonstockvalue": 45580,
    "additionalpaidincapital": 24452684,
    "retainedearningsaccumulateddeficit": -28839179,
    "accumulatedothercomprehensiveincomelossnetoftax": 12345446,
    "stockholdersequity": 17720217,
    "liabilitiesandstockholdersequity": 19473207,
    "allowancefordoubtfulaccountsreceivablecurrent": 18150493,
    "allowancefordoubtfulotherreceivablescurrent": 27289,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 95000000,
    "commonstocksharesissued": 45579557,
    "commonstocksharesoutstanding": 45579557,
    "revenues": 1734233,
    "costofrevenue": 8913543,
    "grossprofit": 1952906,
    "sellingexpense": 2215394,
    "generalandadministrativeexpense": 536035,
    "researchanddevelopmentexpense": 377964,
    "provisionfordoubtfulaccounts": 115186,
    "operatingexpenses": 4531199,
    "operatingincomeloss": -2578293,
    "investmentincomeinterest": 5675,
    "interestexpense": 166388,
    "nonoperatingincomeexpense": -288484,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -2866777,
    "netincomeloss": -536035,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 769227,
    "comprehensiveincomenetoftax": -2097550,
    "earningspersharebasicanddiluted": -0.07,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 43623273,
    "sharesoutstanding": 45579557,
    "foreigncurrencytranslationadjustment": 769227,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 862480,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 2000000,
    "depreciationdepletionandamortization": 2679470,
    "increasedecreaseinaccountsandotherreceivables": 613678,
    "increasedecreaseinprepaidsuppliers": 1708,
    "increasedecreaseininventories": -807592,
    "increasedecreaseinaccountspayabletrade": -214015,
    "increasedecreaseinaccruedliabilities": -15217,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -111160,
    "increasedecreaseincontractwithcustomerliability": 169736,
    "increasedecreaseinprepaidexpense": -8311,
    "netcashprovidedbyusedinoperatingactivities": -319908,
    "paymentstoacquirepropertyplantandequipment": 867307,
    "netcashprovidedbyusedininvestingactivities": -867307,
    "repaymentsofconstructionloanspayable": 2174669,
    "proceedsfromlinesofcredit": 2856066,
    "repaymentsoflinesofcredit": 72489,
    "proceedsfromrelatedpartydebt": 206908,
    "repaymentsofrelatedpartydebt": 191639,
    "netcashprovidedbyusedinfinancingactivities": 338000,
    "effectofexchangerateoncashandcashequivalents": 58156,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -227234,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 957653,
    "restrictedcashandcashequivalents": 957653,
    "interestpaidnet": 237530,
    "accountsreceivablecollectedwithbankersacceptances": 687347,
    "conversionofofficerwagestocommonstock": 864480,
    "inventorypurchasedwithbankersacceptancenote": 682791,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 229673,
    "equitymethodinvestmentownershippercentage": 1,
    "restrictedcashandcashequivalentsatcarryingvalue": 960000,
    "accumulateddeficit": 28600000,
    "capitalrequiredforcapitaladequacy": 700000,
    "increasedecreaseinaccountsreceivable": 687715,
    "linesofcredit": 19700000,
    "baddebtexpense": 115186,
    "inventoryrawmaterials": 2081745,
    "inventoryworkinprocess": 662999,
    "inventoryfinishedgoods": 960375,
    "landandlandimprovements": 431681,
    "buildingsandimprovementsgross": 10024303,
    "machineryandequipmentgross": 29018708,
    "motorvehiclegross": 329660,
    "officeequipmentgross": 259175,
    "propertyplantandequipmentgross": 40063527,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 24499327,
    "propertyplantandequipmentusefullife": "P5Y",
    "depreciation": 2643820,
    "finitelivedintangibleassetsgross": 5173818,
    "finitelivedintangibleassetsaccumulatedamortization": 4991672,
    "finitelivedintangibleassetsnet": 182146,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 37685,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 37685,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 37685,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 37685,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 31406,
    "amortizationofintangibleassets": 35650,
    "intangibleassetsusefullifedescription": "NMPA approval is obtained over their individually identifiable estimated useful life, which range from ten to thirteen years.",
    "duetootherrelatedpartiesclassifiedcurrent": 163825,
    "debtinstrumentinterestrateeffectivepercentage": 0.01,
    "interestexpenserelatedparty": 43083,
    "othernotespayable": 1658706,
    "repaymentofadvance": 191639,
    "duefromrelatedparties": 740316,
    "lineofcreditfacilitymaximumborrowingcapacity": 30000000,
    "lineofcreditfacilitycommitmentfeedescription": "In addition, the agreement calls for the payment of fees equal to 0.05% of the note amount to the bank.",
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 2038345,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 904228,
    "longtermdebt": 2942573,
    "debtinstrumentfaceamount": 300000,
    "lineofcreditfacilitydescription": "The Company obtained a line of credit of RMB 3,200,000 (approximately $0.5 million) from China CITIC Bank in September 2020 and obtained an advance of RMB 2,343,340 (approximately $0.3 million), and the remaining of RMB 856,660 (approximately $0.1 million) in October under this line. The loan bears interest at the rate of 4.50% per annum. The line of credit is due in one year on the anniversary date of the advance.",
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 52814,
    "lesseeoperatingleaseliabilitypaymentsdue": 52814,
    "receivablewithimputedinterestnetamount": 744,
    "operatingleaseliability": 52070,
    "operatingleasecost": 96552,
    "cashpaidforoperatingleases": 102624,
    "operatingleaseweightedaverageremainingleaseterm1": "P0Y6M7D",
    "operatingleaseweightedaveragediscountratepercent": 0.0475,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -716694,
    "incometaxreconciliationchangeinenactedtaxrate": 8190,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 708504,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 4537623,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsprovisionforloanlosses": 6822,
    "deferredtaxassetsinventory": 568182,
    "deferredtaxassetstaxdeferredexpenseother": 1160601,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsimpairmentlosses": 10441373,
    "deferredtaxassetsother": 596,
    "deferredtaxassetstaxcreditcarryforwards": 9542576,
    "operatinglosscarryforwards": 1409380,
    "deferredtaxassetsgross": 27667153,
    "deferredtaxassetsvaluationallowance": 27666557,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 805556,
    "deferredtaxassetsoperatinglosscarryforwards": 37800000,
    "operatinglosscarryforwardsexpirationdate": "2026-12-31",
    "effectiveincometaxratecontinuingoperations": 0.25,
    "netoperatinglosscarryforwardsexpirationdescription": "Approximately $23.1 million of loss carryforwards expired in December 2020. The Company also has net operating losses for United States federal income tax purposes of approximately $6.7 million of which $5.1 million are available to offset future taxable income, if any, through 2039, and $1.6 million are available for carryforward indefinitely subject to a limitation of 80% of taxable income for each tax year.",
    "customersliabilityforacceptancesnet": 53736,
    "fairvaluenetassetliability": 53736,
    "stockissuedduringperiodsharesemployeebenefitplan": 4000000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 175000,
    "statutoryaccountingpracticesstatutorynetincomeamount": 8145000,
    "aftertaxnetincomepercentage": 0.1,
    "reserveaccountbalancespercentage": 0.5,
    "concentrationriskpercentage1": 0.102,
    "numberofcustomers": 3,
    "numberofsuppliers": 3,
    "intercompanyreceivables": 7746779,
    "equitymethodinvestmentaggregatecost": 11705241,
    "otherliabilities": 1752990,
    "increasedecreaseinoperatingliabilities": 216127,
    "proceedsofchangeintercompanyreceivables": 338000,
    "cashandcashequivalentsperiodincreasedecrease": 18092
  },
  {
    "date": "2019-12-30",
    "symbol": "CPHI",
    "period": "FY",
    "entityregistrantname": "CHINA PHARMA HOLDINGS, INC.",
    "entitycentralindexkey": 1106644,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-34471",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "cashandcashequivalentsatcarryingvalue": 3095,
    "restrictedcashandcashequivalents": 109908,
    "bankersacceptances": 45756,
    "receivablesnetcurrent": 635371,
    "accountsandotherreceivablesnetcurrent": 46643,
    "supplies": 404,
    "inventorynet": 3588824,
    "prepaidexpensecurrent": 77120,
    "assetscurrent": 3095,
    "propertyplantandequipmentnet": 16313827,
    "operatingleaserightofuseasset": 136779,
    "intangibleassetsnetexcludinggoodwill": 205611,
    "assets": 19793115,
    "accountspayabletradecurrent": 1366330,
    "accruedliabilitiescurrent": 189880,
    "accountspayableothercurrent": 3560332,
    "customeradvancescurrent": 505398,
    "duetorelatedpartiescurrent": 2071986,
    "operatingleaseliabilitycurrent": 91306,
    "longtermconstructionloancurrent": 2150168,
    "bankacceptancesexecutedandoutstanding": 109908,
    "liabilitiescurrent": 10045308,
    "constructionloannoncurrent": 2150168,
    "operatingleaseliabilitynoncurrent": 48701,
    "deferredtaxliabilitiesnoncurrent": 753444,
    "liabilities": 12997621,
    "commonstockvalue": 43580,
    "additionalpaidincapital": 23590204,
    "retainedearningsaccumulateddeficit": -25972402,
    "accumulatedothercomprehensiveincomelossnetoftax": 11576219,
    "stockholdersequity": 17914157,
    "liabilitiesandstockholdersequity": 19793115,
    "allowancefordoubtfulaccountsreceivablecurrent": 17575100,
    "allowancefordoubtfulotherreceivablescurrent": 22729,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 95000000,
    "commonstocksharesissued": 43579557,
    "commonstocksharesoutstanding": 43579557,
    "revenues": 10923936,
    "costofrevenue": 9441752,
    "grossprofit": 1482184,
    "sellingexpense": 2352610,
    "generalandadministrativeexpense": 522386,
    "researchanddevelopmentexpense": 229637,
    "provisionfordoubtfulaccounts": 3153,
    "assetimpairmentcharges": 17015117,
    "operatingexpenses": 21890037,
    "operatingincomeloss": -20407853,
    "investmentincomeinterest": 27527,
    "interestexpense": 321718,
    "nonoperatingincomeexpense": -294191,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -20702044,
    "netincomeloss": -522386,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -259130,
    "comprehensiveincomenetoftax": -20961174,
    "earningspersharebasicanddiluted": -0.48,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 43579557,
    "sharesoutstanding": 43579557,
    "depreciationdepletionandamortization": 2928799,
    "inventorywritedown": 253465,
    "increasedecreaseinaccountsandotherreceivables": 478918,
    "increasedecreaseinprepaidsupplies": 361,
    "increasedecreaseininventories": -1999978,
    "increasedecreaseinaccountspayabletrade": 324180,
    "increasedecreaseinaccruedtaxespayable": 12971,
    "increasedecreaseinaccruedliabilities": 378200,
    "increasedecreaseinotheraccountspayableandaccruedliabilities": -1158728,
    "increasedecreaseincustomeradvances": -12875,
    "increasedecreaseinprepaidexpense": -45375,
    "netcashprovidedbyusedinoperatingactivities": -302075,
    "paymentstoacquirepropertyplantandequipment": 136003,
    "netcashprovidedbyusedininvestingactivities": -136003,
    "repaymentsofconstructionloanspayable": 2174399,
    "proceedsfromrelatedpartydebt": 691459,
    "proceedsfromrepaymentsofrelatedpartydebt": -245830,
    "netcashprovidedbyusedinfinancingactivities": 300000,
    "effectofexchangerateoncashandcashequivalents": -19179,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1275640,
    "cashandcashequivalentatcarryingvalue": 2460527,
    "cashandcashequivalent": 1074979,
    "restrictedcashandcashequivalent": 109908,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalent": 1184887,
    "interestpaidnet": 299164,
    "accountsreceivablecollectedwithbankersacceptancenote": 869625,
    "inventorypurchasedwithbankersacceptancenote": 843867,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 229644,
    "equitymethodinvestmentownershippercentage": 1,
    "restrictedcashandcashequivalentsatcarryingvalue": 1100000,
    "accumulateddeficit": 26000000,
    "capitalrequiredforcapitaladequacy": 691459,
    "constructionloan": 2000000,
    "inventoryrawmaterials": 2113994,
    "inventoryworkinprocess": 314231,
    "inventoryfinishedgoods": 1160599,
    "landandlandimprovements": 403755,
    "buildingsandimprovementsgross": 9375817,
    "machineryandequipmentgross": 26309262,
    "motorvehiclegross": 308334,
    "officeequipmentgross": 217058,
    "propertyplantandequipmentgross": 36614226,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 20300399,
    "propertyplantandequipmentusefullife": "P5Y",
    "depreciation": 2871134,
    "finitelivedintangibleassetsgross": 4839117,
    "finitelivedintangibleassetsaccumulatedamortization": 4633506,
    "finitelivedintangibleassetsnet": 205611,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 35248,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 35248,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 35248,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 35248,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 35248,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 29371,
    "amortizationofintangibleassets": 57665,
    "goodwillimpairmentloss": 17015117,
    "debtinstrumentinterestrateeffectivepercentage": 0.01,
    "interestexpenserelatedparty": 12393,
    "duetootherrelatedpartiesclassifiedcurrent": 667440,
    "othernotespayable": 2307986,
    "lineofcreditfacilitymaximumborrowingcapacity": 30000000,
    "lineofcreditfacilitycommitmentfeedescription": "In addition, the agreement calls for the payment of fees equal to 0.05% of the note amount to the bank.",
    "notesandloanspayable": 109908,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 2150168,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 2150168,
    "longtermdebt": 4300336,
    "debtinstrumentfaceamount": 15000000,
    "operatingleasesfutureminimumpaymentsduecurrent": 95986,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 49397,
    "undiscountedcashflows": 145383,
    "receivablewithimputedinterestnetamount": 5376,
    "operatingleasesfutureminimumpaymentsdue": 140007,
    "operatingleaseliabilitiescurrentportion": -91306,
    "operatingleaseliability": 48701,
    "operatingleasecost": 90306,
    "otheroperatingactivitiescashflowstatement": 95985,
    "operatingleaserightuseofliabilities": 140007,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y6M7D",
    "operatingleaseweightedaveragediscountratepercent": 0.0475,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -5175512,
    "incometaxreconciliationchangeinenactedtaxrate": 8103,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 5167409,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsallowancefordoubtfulaccounts": 4393775,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsprovisionforloanlosses": 5682,
    "deferredtaxassetsinventory": 1528482,
    "deferredtaxassetstaxdeferredexpenseother": 1085520,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsimpairmentlosses": 9765906,
    "deferredtaxassetsother": 807,
    "deferredtaxassetstaxcreditcarryforwards": 12682671,
    "operatinglosscarryforwards": 1296813,
    "deferredtaxassetsgross": 30759656,
    "deferredtaxassetsvaluationallowance": 30759656,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 753444,
    "deferredtaxassetsoperatinglosscarryforwards": 50000000,
    "operatinglosscarryforwardsexpirationdate": "2024-12-31",
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 5100000,
    "effectiveincometaxratecontinuingoperations": 0.25,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.25,
    "netoperatinglosscarryforwardsexpirationdescription": "Approximately $3.8 million of these carryforwards expired in December 2019. The Company also has net operating losses for United States federal income tax purposes of approximately $6.2 million of which $5.1 million which are available to offset future taxable income, if any, through 2038, and $1.1 million are available for carryforward indefinitely subject to a limitation of 80% of taxable income for each tax year.",
    "customersliabilityforacceptancesnet": 45756,
    "fairvaluenetassetliability": 45756,
    "stockissuedduringperiodsharesemployeebenefitplan": 4000000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 175000,
    "statutoryaccountingpracticesstatutorynetincomeamount": 8145000000,
    "aftertaxnetincomepercentage": 0.1,
    "reserveaccountbalancespercentage": 0.5,
    "concentrationriskpercentage1": 0.058,
    "numberofcustomers": 2,
    "numberofsuppliers": 3,
    "intercompanyreceivables": 8084779,
    "equitymethodinvestmentaggregatecost": 11705241,
    "otherliabilities": 2401344,
    "increasedecreaseinoperatingliabilities": 220311,
    "proceedsofchangeintercompanyreceivables": 300000,
    "cashandcashequivalentsperiodincreasedecrease": -2075
  }
]